CA2498267C - Methode pour traiter la dyserection et augmenter la libido chez l'homme - Google Patents

Methode pour traiter la dyserection et augmenter la libido chez l'homme Download PDF

Info

Publication number
CA2498267C
CA2498267C CA2498267A CA2498267A CA2498267C CA 2498267 C CA2498267 C CA 2498267C CA 2498267 A CA2498267 A CA 2498267A CA 2498267 A CA2498267 A CA 2498267A CA 2498267 C CA2498267 C CA 2498267C
Authority
CA
Canada
Prior art keywords
day
testosterone
men
patch
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA2498267A
Other languages
English (en)
Other versions
CA2498267A1 (fr
Inventor
Robert E. Dudley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Unimed Pharmaceuticals LLC
Original Assignee
Unimed Pharmaceuticals LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unimed Pharmaceuticals LLC filed Critical Unimed Pharmaceuticals LLC
Priority to CA2498267A priority Critical patent/CA2498267C/fr
Priority claimed from CA002420895A external-priority patent/CA2420895C/fr
Publication of CA2498267A1 publication Critical patent/CA2498267A1/fr
Application granted granted Critical
Publication of CA2498267C publication Critical patent/CA2498267C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0034Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
CA2498267A 2001-08-29 2001-08-29 Methode pour traiter la dyserection et augmenter la libido chez l'homme Expired - Lifetime CA2498267C (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA2498267A CA2498267C (fr) 2001-08-29 2001-08-29 Methode pour traiter la dyserection et augmenter la libido chez l'homme

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CA2498267A CA2498267C (fr) 2001-08-29 2001-08-29 Methode pour traiter la dyserection et augmenter la libido chez l'homme
CA002420895A CA2420895C (fr) 2000-08-30 2001-08-29 Methode pour traiter la dyserection et augmenter la libido chez l'homme

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CA002420895A Division CA2420895C (fr) 2000-08-30 2001-08-29 Methode pour traiter la dyserection et augmenter la libido chez l'homme

Publications (2)

Publication Number Publication Date
CA2498267A1 CA2498267A1 (fr) 2002-03-07
CA2498267C true CA2498267C (fr) 2010-10-26

Family

ID=34427647

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2498267A Expired - Lifetime CA2498267C (fr) 2001-08-29 2001-08-29 Methode pour traiter la dyserection et augmenter la libido chez l'homme

Country Status (1)

Country Link
CA (1) CA2498267C (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060127483A1 (en) * 2004-12-10 2006-06-15 Alan Drizen Topical drug delivery system

Also Published As

Publication number Publication date
CA2498267A1 (fr) 2002-03-07

Similar Documents

Publication Publication Date Title
EP1315502B1 (fr) Methode pour traiter la dyserection et augmenter la libido chez l'homme
ZA200301687B (en) Method for treating erectile dysfunction and increasing libido in men.
US20030139384A1 (en) Method for treating erectile dysfunction and increasing libido in men
AU2001286995A1 (en) Method for treating erectile dysfunction and increasing libido in men
CA2451725C (fr) Combinaisons therapeutiques pour le traitement des carences hormonales
US20150250801A1 (en) Androgen pharmaceutical composition and method for treating depression
US20090318398A1 (en) Androgen pharmaceutical composition and method for treating depression
AU2003228314B8 (en) Androgen pharmaceutical composition and method for treating depression
CA2498267C (fr) Methode pour traiter la dyserection et augmenter la libido chez l'homme
RU2303981C2 (ru) Способ лечения эректильной дисфункции и повышения либидо у мужчин
CA2501846A1 (fr) Combinaisons therapeutiques pour le traitement des carences hormonales

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20210830